Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

NIH 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Endocrine 2Dermatologic 1

Conditions

Neoplasm Metastasis 9Colorectal Neoplasms 8Rectal Neoplasms 7Liver Neoplasms 7Carcinoma, Hepatocellular 7Colonic Neoplasms 6Rhabdomyosarcoma 4Hepatoblastoma 4Wilms Tumor 3Sarcoma, Ewing 3Sarcoma 3Rhabdoid Tumor 3Retinoblastoma 3Neuroblastoma 3Melanoma 3Medulloblastoma 3Central Nervous System Neoplasms 3Carcinoma, Renal Cell 3Uveal Melanoma 2Pancreatic Neoplasms 2Neoplasms, Germ Cell and Embryonal 2Neoplasms 2Kidney Neoplasms 2Hyperthermia 2Carcinoma, Islet Cell 2Brain Neoplasms 2Astrocytoma 2Appendiceal Neoplasms 2Vipoma 1Testicular Neoplasms 1

Interventions

Trastuzumab 2Oxaliplatin 2Melphalan 2Leucovorin 2tipifarnib 1napabucasin 1irinotecan sucrosofate 1folfirinox 1Temozolomide 1Taxes 1Sunitinib 1Paclitaxel 1Irinotecan 1Interleukin-12 Subunit p35 1Interleukin-12 1Granulocyte Colony-Stimulating Factor 1Gemcitabine 1Fluorouracil 1Floxuridine 1Filgrastim 1Fentanyl 1Everolimus 1Cytokines 1Capecitabine 1Bevacizumab 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Carcinoma, Islet Cell × Melphalan × Gastrointestinal × Clear all
NCT00096083 2013-10-23

Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer

Delcath Systems Inc.

Phase 2 Completed
56 enrolled
DermatologicEndocrineGastrointestinal

Adenocarcinoma Of Esophagus, Uveal Melanoma, Appendiceal Neoplasms, Bile Duct Neoplasms, Colonic Neoplasms, Vipoma, Esophageal Neoplasms, Gallbladder Neoplasms, Glucagonoma, Carcinoma, Hepatocellular, Insulinoma, Melanoma, Neoplasms, Pancreatic Neoplasms, Pheochromocytoma, Rectal Neoplasms, Somatostatinoma, Stomach Neoplasms, Carcinoma, Islet Cell, Carcinoma, Medullary

NCT00019786 2012-03-23

Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
67 enrolled
EndocrineGastrointestinal

Colonic Neoplasms, Carcinoma, Hepatocellular, Adenoma, Islet Cell, Liver Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms, Carcinoma, Islet Cell, Carcinoma, Neuroendocrine

Data powered by HemOnc (CC BY 4.0) Colophon âš¡